Literature DB >> 8796290

Plasminogen activators, kallikrein-like proteinase and type I and type IV collagenases at various stages of oncogenic transformation.

N I Solovyeva1, T O Balayevskaya, E A Dilakyan, L Z Topol, F L Kisseliov.   

Abstract

Comparative studies of membrane-associated, intracellular and secreted activities of serine (uPA, kallikrein-like proteinase) and metalloproteinases (type I and IV collagenases) were carried out on rat embryo fibroblasts, sequentially immortalized and transformed by two different genes. Using this experimental model it was shown that (1) activity of uPA was expressed at the stage of immortalization solely; (2) intracellular and secreted activity of type I and IV collagenases decreased during process of transformation, (3) kallikrein-like proteinase activity was not revealed either in the primary or in transformed cells, (4) Z-Phe-Arg-MCA hydrolysis was the result of the action of cysteine proteinases alone; the increase in this activity was correlated with the stages of oncogenic transformation of fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796290     DOI: 10.1016/0162-3109(95)00074-7

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  1 in total

1.  Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation.

Authors:  Zhiqun Shang; Yuanjie Niu; Qiliang Cai; Jing Chen; Jing Tian; Shuyuan Yeh; Kuo-Pao Lai; Chawnshang Chang
Journal:  Tumour Biol       Date:  2014-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.